HIPEC in T4a colon cancer: a defendable treatment to improve oncologic outcome?

@article{Hompes2012HIPECIT,
  title={HIPEC in T4a colon cancer: a defendable treatment to improve oncologic outcome?},
  author={Daphne Hompes and Joyce Tiek and Albert M. Wolthuis and Steffen Fieuws and Freddy M. Penninckx and Eric Van Cutsem and Andr{\'e} D'Hoore},
  journal={Annals of oncology : official journal of the European Society for Medical Oncology},
  year={2012},
  volume={23 12},
  pages={3123-9}
}
BACKGROUND Adequate estimation of the potential benefits of 'adjuvant' hyperthermia and intraperitoneal chemotherapy (HIPEC) in T4 patients through assessment of the burden of peritoneal carcinomatosis (PC) in T4 tumors and the risk of PC as the only metastatic site. PATIENTS AND METHODS Analysis of prospectively collected data on patients who underwent surgery for colon cancer (Jan 2004-Jan 2007). RESULTS About 379 patients (M/F = 204/175) were included, with a median age of 71.8 years… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS